Influenza Vaccine (Split Virion), Inactivated, Quadrivalent (Zhejiang Tianyuan Bio-Pharmaceutical)

四价流感病毒裂解疫苗（浙江天元生物）

Report date: 2025/07/10 17:17:19

Base Information

Drug NameInfluenza Vaccine (Split Virion), Inactivated, Quadrivalent (Zhejiang Tianyuan Bio-Pharmaceutical)
Drug Alias NameN/A
ClassificationVaccines > Vaccine type > Multivalent vaccineVaccines > Development/production technology > Inactivated vaccine > Split vaccineVaccines > Application > Prophylactic vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza, HumanCommon Cold
Global Approved IndicationsInfluenza, Human
Approved Indications in ChinaInfluenza, Human
Original Approved Country/TerritoryMainland China
Original Approved Date2025/07/08
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesZhejiang Tianyuan Bio-Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesZhejiang Tianyuan Bio-Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsInfluenza, HumanCommon Cold
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A